myxo- and paramyxoviruses ( and other viruses ) upgrade the immunogenicity of cell surface antigens thus eliciting rejection type host immunity against these cells which is operational against not virus-infected cells of the same type ( post-oncolytic antitumor immunity ) .
C0003320
antigens
C0020964
immunity